Onderzoeker
Matthias Rombaut
- Trefwoorden:Farmacie
- Disciplines:Hepatologie, Ontwikkelingsbiologie, Biofarmaceutica
Affiliaties
- Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf26 okt 2018 → Heden - Experimentele in vitro toxicologie en dermato-cosmetologie (Onderzoeksgroep)
Lid
Vanaf3 okt 2015 → Heden - Farmaceutische en Farmacologische Wetenschappen (Departement)
Lid
Vanaf1 jan 2024 → Heden - Farmaceutische en Farmacologische Wetenschappen (Departement)
Lid
Vanaf1 jan 2019 → 31 dec 2023 - Farmaceutische en Farmacologische Wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → 20 okt 2022 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf21 sep 2017 → 27 jun 2018 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf3 okt 2015 → 29 jun 2017
Projecten
1 - 1 of 1
- Verbeter de herprogrammering van fibroblasten, bekomen uit volwassen huidweefsel, naar functionele levercellen via gerichte evolutie van hepatocyt nucleaire factorenVanaf1 jan 2019 → 31 dec 2023Financiering: FWO mandaten
Publicaties
1 - 10 van 10
- Light triggered nanoscale biolistics for efficient intracellular delivery of functional macromolecules in mammalian cells(2022)
Auteurs: Juan C Fraire, Elnaz Shaabani, Maryam Sharifiaghdam, Matthias Rombaut, Charlotte Hinnekens, Dawei Hua, Jana Ramon, Laurens Raes, Eduardo Bolea-Fernandez, Toon Brans, et al.
- Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease(2022)
Auteurs: Gigly Del'Haye, Ine Nulmans, Sandrine Paula Bouteille, Karolien Sermon, Brecht Wellekens, Matthias Rombaut, Tamara Vanhaecke, Yvan Vander Heyden, Joery De Kock
Pagina's: 2881-2897 - Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery(2022)
Auteurs: Joost Boeckmans, Alexandra Gatzios, Anja Heymans, Matthias Rombaut, V. Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Rodrigues
- From NAFLD to MAFLD: Aligning translational in vitro research to clinical insights(2022)
Auteurs: Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim Rodrigues, Vera Rogiers, Tamara Vanhaecke, Joost Boeckmans
- Direct reprogramming of somatic cells into induced hepatocytes(2021)
Auteurs: Matthias Rombaut, Joost Boeckmans, Robim Rodrigues, Leo A van Grunsven, Tamara Vanhaecke, Joery De Kock
Pagina's: 690-705 - Infections at the nexus of metabolic-associated fatty liver disease(2021)
Auteurs: Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Pierard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, et al.
Pagina's: 2235-2253 - Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists(2021)
Auteurs: Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Brent Cami, Veerle De Boe, Anja Heymans, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, et al.
Pagina's: 293-311 - Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells(2020)
Auteurs: Joery De Kock, Robim Marcelino Rodrigues, Steven Branson, Lieven Verhoye, Haaike Colemonts-Vroninks, Matthias Rombaut, Joost Boeckmans, Jessie Neuckermans, Sien Lequeue, Karolien Buyl, et al.
- Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH(2020)
Auteurs: Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Tamara Vanhaecke, Vera Rogiers, Robim Rodrigues, Joery De Kock
- Anti-NASH Drug Development Hitches a Lift on PPAR Agonism(2019)
Auteurs: Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Rodrigues
Pagina's: 1-20